Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Evolutionary Relationships through Genome Comparisons

Evolutionary Relationships through Genome Comparisons

Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...

Genomics

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...

Bioequivalence: Overview

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Burden of Diagnosed Diabetes among People With and Without HIV in Uganda: a Cross-Sectional Analysis of the Rakai Community Cohort Study.

Research square·2026

Same author

High KIR diversity in Uganda and Botswana children living with HIV.

Human immunology·2026

Same author

Clinical profiles of patients with antibiotic-resistant infections at select tertiary hospitals in Uganda: a retrospective study of clinical records.

BMC infectious diseases·2026

Same author

Machine Learning Identifies Potential Accessory Resistance-Associated Mutations in HIV-1 Integrase.

Research square·2026

Same author

Potential of machine learning for prevention and control of neglected tropical diseases: a scoping review.

Communications medicine·2026

Same author

The epidemiology of SARS-CoV-2, Influenza, and Respiratory Syncytial Virus circulation among adult patients with acute respiratory illness in Kampala Metropolitan Area in Uganda.

PloS one·2026

Same journal

The cell cloud: Adopting systems biology concepts in the era of single-cell immunology.

PLoS biology·2026

Same journal

Disinhibitory signaling enables flexible coding of top-down information in cortical networks.

PLoS biology·2026

Same journal

Correction: Cdc42 interacts with chaperone Ydj1 to enhance its stability and partitioning during asymmetric cell division and aging in yeast.

PLoS biology·2026

Same journal

The human claustrum supports cognitive networks for externally and internally driven task demands.

PLoS biology·2026

Same journal

Unusual decay: Recombination loss leads to splicing errors in green algae.

PLoS biology·2026

Same journal

Angptl5 restricts primitive hematopoiesis by promoting retinoic acid signaling in zebrafish.

PLoS biology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved (Non-model) Organisms

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved (Non-model) Organisms

Published on: May 9, 2017

Towards globally equitable bioinformatics adoption.

Paulyna Magaña¹, Piraveen Gopalasingam¹, Jennifer R Fleming¹

¹EMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.

|July 1, 2026

Summary

This summary is machine-generated.

Artificial intelligence (AI)-driven bioinformatics offers democratized discovery, but significant inequities remain. Equitable tool adoption requires investment in infrastructure, training, institutions, and global communities, beyond mere access.

More Related Videos

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Related Experiment Videos

Last Updated: Jul 3, 2026

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved (Non-model) Organisms

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved (Non-model) Organisms

Published on: May 9, 2017

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Area of Science:

Bioinformatics
Artificial Intelligence
Health Equity

Background:

Artificial intelligence (AI) is revolutionizing bioinformatics, promising wider access to scientific discovery.
Despite advancements, significant inequities in the adoption and utilization of these powerful tools persist globally.

Purpose of the Study:

To highlight the persistent inequities in the adoption of AI-driven bioinformatics tools.
To outline the necessary components for achieving equitable access and utilization of these technologies.

Main Methods:

This study is a conceptual analysis and synthesis of current trends in AI-driven bioinformatics and global health equity.

Main Results:

AI in bioinformatics promises democratized scientific discovery.
Major inequities in the adoption and effective use of bioinformatics tools currently exist.
Access alone is insufficient to ensure equitable adoption.

Conclusions:

Equitable adoption of AI-driven bioinformatics tools necessitates substantial and sustained investment.
Investment must encompass infrastructure, comprehensive training programs, institutional support, and the cultivation of global scientific communities.
Addressing these multifaceted requirements is crucial for realizing the full potential of bioinformatics for all researchers.